Wuxi Pharmatech Inc., of Shanghai, entered a syndicated loan facility to borrow up to $165 million from a consortium of banks in Asia led by Citibank. The borrowing will incur interest at a rate of LIBOR plus 2.89 percent, including all expenses, and will be repaid in four installments over 18 months to 36 months, the company said.